Enimmune Corporation (TPEX:6564)
13.60
-1.10 (-7.48%)
Nov 20, 2026, 1:50 PM CST
| Market Cap | 981.02M -33.3% |
| Revenue (ttm) | 53.45M +26.6% |
| Net Income | -120.88M |
| EPS | -1.68 |
| Shares Out | 72.13M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 132,533 |
| Open | 14.30 |
| Previous Close | 14.70 |
| Day's Range | 13.55 - 14.35 |
| 52-Week Range | 13.50 - 22.55 |
| Beta | 0.25 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 26, 2026 |